The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - HistoGeneX
Leadership - HistoGeneX
Stock and Other Ownership Interests - HistoGeneX
Honoraria - HistoGeneX
Consulting or Advisory Role - HistoGeneX
Speakers' Bureau - Roche
Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab.
 
Kelly Schats
Employment - HistoGeneX
Leadership - HistoGeneX
Research Funding - HistoGeneX
 
Emily A. Van Vre
Employment - HistoGeneX
Leadership - HistoGeneX
 
Isolde Debyser
Employment - HistoGeneX
Leadership - HistoGeneX
 
Arno Vandenbroeck
Employment - HistoGeneX
Leadership - HistoGeneX
 
Yanina Jansen
Travel, Accommodations, Expenses - MSD; Pfizer
 
Teofila Seremet
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - ASIT Biotech (I); GlaxoSmithKline (I)
Honoraria - Novartis
Travel, Accommodations, Expenses - Novartis
 
Koen Marien
Employment - HistoGeneX
Leadership - HistoGeneX
 
Erik Fransen
No Relationships to Disclose
 
Dorien Schrijvers
Employment - HistoGeneX
Leadership - HistoGeneX
 
Wim Van Criekinge
Employment - University of Ghent
Leadership - MDxHealth
Stock and Other Ownership Interests - MDxHealth
Honoraria - MDxHealth
Consulting or Advisory Role - MDxHealth
Research Funding - MDxHealth
Patents, Royalties, Other Intellectual Property - MDHealth; University of Ghent
 
Kris Thielemans
Stock and Other Ownership Interests - EteRNA
Consulting or Advisory Role - EteRNA
Patents, Royalties, Other Intellectual Property - EteRNA
Expert Testimony - EteRNA
Travel, Accommodations, Expenses - EteRNA
 
Bart Neyns
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Cryostorage; Etherna; MSD; Novartis; Roche
Speakers' Bureau - Novartis
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
 
Ingrid De Meester
No Relationships to Disclose
 
Mark Kockx
No Relationships to Disclose